C79.51

Clinical Causes: Primary cancers that commonly spread to bones include breast, prostate, lung, kidney, and thyroid cancers. Cancer cells detach from the primary tumor and enter the circulation, eventually lodging in the bone marrow. Certain factors, such as advanced stage of cancer and specific tumor types, increase the likelihood of bone metastasis. Genetic mutations in cancer cells may also influence their ability to invade bone tissue.

Key Symptoms: Bone pain, which may intensify over time and can be persistent or intermittent. Swelling or a palpable lump around affected bones. Pathological fractures, which occur with minimal trauma due to weakened bones. Hypercalcemia symptoms, such as nausea, vomiting, constipation, and confusion, resulting from calcium release from the damaged bones. Reduced mobility or difficulty moving affected limbs or joints. Unintended weight loss and general decline in health.

Diagnosis Path: X-rays to detect bone abnormalities and fractures. Bone scans, such as Technetium-99m scintigraphy, to identify areas of increased bone activity indicative of metastases. Magnetic Resonance Imaging (MRI) for detailed visualization of bone and surrounding soft tissues. Computed Tomography (CT) scans for precise imaging of bone lesions. Biopsy procedures to analyze tissue samples and confirm cancerous cells. Blood tests to evaluate calcium levels and markers associated with bone turnover.

Treatment Protocols: Systemic therapies such as chemotherapy, targeted therapy, or hormonal therapy, tailored according to the primary cancer type. Radiation therapy to reduce tumor size, relieve pain, and strengthen bones. Surgical interventions for fracture stabilization or removal of localized tumor deposits. Bisphosphonates or denosumab to strengthen bones and reduce skeletal-related events. Palliative care focused on symptom management, including pain control and supportive therapies.